{"id":"W2806800866","doi":"10.1200/jco.2018.36.15_suppl.1031","title":"Serum PD-L1 and outcomes in CCTG MA.31 phase 3 trial of anti-HER2 therapy in first-line HER2+ metastatic breast cancer patients (trastuzumab arm only).","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of British Columbia; Queen's University","funders":"","keywords":"Medicine; Trastuzumab; Internal medicine; Metastatic breast cancer; Oncology; Lapatinib; Taxane; Breast cancer; Univariate analysis; Cancer; Multivariate analysis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001488912,0.0007317973,0.0009905499,0.0003035172,0.0003035065,0.0009992745,0.000577352,0.0008778839,0.002642587],"category_scores_gemma":[0.001701365,0.000277876,0.0008173215,0.000353797,0.0003153326,0.0004409415,0.0003479165,0.002202582,0.0005520885],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0015405,"about_ca_system_score_gemma":0.001569736,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002779186,"about_ca_topic_score_gemma":0.009280118,"domain_scores_codex":[0.9994367,0.0003110497,0.0000209528,0.00005360875,0.00007274204,0.0001048213],"domain_scores_gemma":[0.9990692,0.0001646235,0.0002688133,0.00007266081,0.00007016891,0.0003546293],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7701115,0.01247757,0.08875076,0.0007445297,0.003710289,0.0004134373,0.0002723596,0.003209197,0.01786915,0.0005618692,0.03291275,0.06896662],"study_design_scores_gemma":[0.3609909,0.2341472,0.3775242,0.0002449182,0.002985961,0.0007533383,0.0001426011,0.006667641,0.00354839,0.0006363306,0.01226975,0.00008870266],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909406,0.003868144,0.0001258219,0.0007700883,0.00009557941,0.0004236868,0.001697864,0.00004032335,0.002038006],"genre_scores_gemma":[0.9916089,0.0007481655,0.0001672876,0.000636254,0.000198142,0.0005851507,0.004244756,0.00001489694,0.001796391],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002779186,"threshold_uncertainty_score":0.01117712,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0924004381767024,"score_gpt":0.4892809865557027,"score_spread":0.3968805483790003,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}